Abstract
A lentiviral vaccine, live attenuated equine infectious anemia virus (EIAV) vaccine, was developed in the 1970s, and this has made tremendous contributions to the control of equine infectious anemia (EIA) in China. Four key virus strains were generated during the attenuation of the EIAV vaccine: the original Liao-Ning strain (EIAVLN40), a donkey-adapted virulent strain (EIAVDV117), a donkey-leukocyte-attenuated vaccine strain (EIAVDLV121), and a fetal donkey dermal cell (FDD)-adapted vaccine strain (EIAVFDDV13). In this study, we analyzed the proviral genomes of these four EIAV strains and found a series of consensus substitutions among these strains. These mutations provide useful information for understanding the genetic basis of EIAV attenuation. Our results suggest that multiple mutations in a variety of genes in our attenuated EIAV vaccines not only provide a basis for virulence attenuation and induction of protective immunity but also greatly reduce the risk of reversion to virulence.
Similar content being viewed by others
References
Carpenter S, Alexandersen S, Long MJ, Perryman S, Chesebro B (1991) Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J Virol 65:1605–1610
Cook SJ, Cook RF, Montelaro RC, Issel CJ (2001) Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus. Vet Microbiol 79:93–109
Craigo JK, Zhang B, Barnes S, Tagmyer TL, Cook SJ, Issel CJ, Montelaro RC (2007) Envelope variation as a primary determinant of lentiviral vaccine efficacy. Proc Natl Acad Sci USA 104:15105–15110
Edwards TG, Wyss S, Reeves JD, Zolla-Pazner S, Hoxie JA, Doms RW, Baribaud F (2002) Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein. J Virol 76:2683–2691
Fagerness AJ, Flaherty MT, Perry ST, Jia B, Payne SL, Fuller FJ (2006) The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies. Virology 349:22–30
Howe L, Leroux C, Issel CJ, Montelaro RC (2002) Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. J Virol 76:10588–10597
Jia B (2004) Role of the cytoplasmic tall of equine infectious anemia virus transmembrane glycoprotein in acute disease induction. Dissertation, North Carolina State University
Jiang C, Ma J, Gao X, Lin Y, Zhao L, Hua Y, Liu D, Zhou J (2010) Effects on in vitro replication of equine infectious anemia virus attenuated vaccine strain with truncated mutation in the transmembrane protein. Prog Biochem Biophys 37:261–268
Jin S, Chen C, Montelaro RC (2005) Equine infectious anemia virus Gag p9 function in early steps of virus infection and provirus production. J Virol 79:8793–8801
Leroux C, Cadore JL, Montelaro RC (2004) Equine Infectious Anemia Virus (EIAV): what has HIV’s country cousin got to tell us? Vet Res 35:485–512
Li F, Puffer BA, Montelaro RC (1998) The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro. J Virol 72:8344–8348
Lichtenstein DL, Craigo JK, Leroux C, Rushlow KE, Cook RF, Cook SJ, Issel CJ, Montelaro RC (1999) Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo. Virology 263:408–417
Lonning SM, Zhang W, McGuire TC (1999) Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses. J Virol 73:4257–4265
Ma J, Shi N, Cheng J, Lin Y, Wang X, Wang S, Lv X, Zhao L, Shao Y, Kong X, Zhou J, Shen R (2011) A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity. Virology. doi:10.1016/j.virol.2010.10.032
Ma J, Jiang C, Lin Y, Wang X, Zhao L, Xiang W, Shao Y, Shen R, Kong X, Zhou J (2009) In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine. Arch Virol 154:867–873
McBurney SP, Ross TM (2008) Viral sequence diversity: challenges for AIDS vaccine designs. Expert Rev Vaccines 7:1405–1417
Miyazawa T, Tomonaga K, Kawaguchi Y, Kohmoto M, Inoshima Y, Maeda K, Mikami T, Maedadel K (1994) Effects of insertion of multiple AP-1 binding sites into the U3 region of the long terminal repeat of feline immunodeficiency virus. Arch Virol 139:37–48
Payne SL, La Celle K, Pei XF, Qi XM, Shao H, Steagall WK, Perry S, Fuller F (1999) Long terminal repeat sequences of equine infectious anaemia virus are a major determinant of cell tropism. J Gen Virol 80(Pt 3):755–759
Payne SL, Pei XF, Jia B, Fagerness A, Fuller FJ (2004) Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus. J Virol 78:2478–2485
Qi X, Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Shen R, Wang F, Kong X, Su Z, Zhou J (2010) Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13. Virus Genes 41:86–98
Shang L, Yue L, Hunter E (2008) Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection. J Virol 82:5417–5428
Shen RX, Wang Z (1985) Development and use of an equine infectious anemia donkey leucocyte attenuated vaccine. EIAV: a national review of policies programs and future objectives. American Quarter Horse Association, Amarillo, pp 135–148
Terme JM, Calvignac S, Duc Dodon M, Gazzolo L, Jordan A (2009) E box motifs as mediators of proviral latency of human retroviruses. Retrovirology 6:81
Wang XF, Jiang CG, Guo W, Xiang W, Lv XL, Zhao LP, Wang FL, Kong XG, Zhang XY, Shao YM, Zhou JH (2008) Comparison of proviral genomes between the Chinese EIAV donkey leukocyte-attenuated vaccine and its parental virulent strain. Bing Du Xue Bao 24:443–450
Zhang W, Lonning SM, McGuire TC (1998) Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J Virol 72:9612–9620
Zheng YH, Sentsui H, Kono Y, Ikuta K (2000) Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages. Virus Res 68:93–98
Zheng YH, Sentsui H, Sugita M, Nakaya T, Kishi M, Hagiwara K, Inoshima Y, Ishihara C, Kono Y, Lu JL, Ikuta K (2000) Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain. Virology 266:129–139
Acknowledgments
This study was funded by National Special Fund for Control and Treatment of Major Infectious Diseases (Grant 2008ZX1001-1010 to JZ), National Natural Science Foundation of China (30771994 to JZ and 30901349 to YL).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, X., Wang, S., Lin, Y. et al. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains. Arch Virol 156, 353–357 (2011). https://doi.org/10.1007/s00705-010-0877-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-010-0877-8